Enzyme Replacement Therapy in Mucopolysaccharidosis I: Altered Distribution and Targeting of α-l-Iduronidase in Immunized Rats

By Turner C.T.   Hopwood J.J.   Brooks D.A.  

Molecular Genetics and Metabolism, Vol. 69, Iss. 4, 2000-04 ,pp. : 277-285

Academic Press

Access to resources Recommend Favorite

Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease

By Altarescu G.   Schiffmann R.   Parker C.C.   Moore D.F.   Kreps C.   Brady R.O.   Barton N.W.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 4, 2000-08 ,pp. : 285-290

Academic Press

Access to resources Recommend Favorite

Decreased Bone Density in Splenectomized Gaucher Patients Receiving Enzyme Replacement Therapy

By Schiffmann R.   Mankin H.   Dambrosia J.M.   Xavier R.J.   Kreps C.   Hill S.C.   Barton N.W.   Rosenthal D.I.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 288-296

Academic Press

Access to resources Recommend Favorite

Commentary: Dosage–Response in the Treatment of Gaucher Disease by Enzyme Replacement Therapy

By Beutler E.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 4, 2000-08 ,pp. : 303-306

Academic Press

Access to resources Recommend Favorite

Low-Dose High-Frequency Enzyme Replacement Therapy Prevents Fractures without Complete Suppression of Painful Bone Crises in Patients with Severe Juvenile Onset Type I Gaucher Disease

By Cohen I.J.   Katz K.   Kornreich L.   Horev G.   Frish A.   Beutler R.E.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 3, 1998-09 ,pp. : 296-302

Academic Press

Access to resources Recommend Favorite